Swedish researchers at the Sahlgrenska Academy of the University of Gothenburg have uncovered a specific group of nerve cells in the brain stem that appears to control how the anti-diabetic medication semaglutide affects appetite and weight — without causing nausea. Specifically, they demonstrate that it is possible to distinguish the nerve cells in the brain that control beneficial effects — such as reduced food intake and fat loss — from those that contribute to side effects.
